Menu Search
Equities

IRIDEX Corp

IRIX:NAQ

IRIDEX Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.89
  • Today's Change-0.05 / -2.58%
  • Shares traded21.41k
  • 1 Year change-10.85%
  • Beta0.7978
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year IRIDEX Corp's revenues fell -8.96% from 56.97m to 51.87m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 7.55m to a larger loss of 9.57m.
Gross margin40.44%
Net profit margin-21.85%
Operating margin-21.53%
Return on assets-31.84%
Return on equity-122.71%
Return on investment-54.55%
More ▼

Cash flow in USDView more

In 2023, cash reserves at IRIDEX Corp fell by 6.89m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 6.75m for operations while cash used for investing totalled 109.00k.
Cash flow per share-0.6342
Price/Cash flow per share--
Book value per share0.2581
Tangible book value per share0.1098
More ▼

Balance sheet in USDView more

IRIDEX Corp uses little or no debt in its capital structure.
Current ratio1.55
Quick ratio0.8599
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.